Lynn L. Bergeson is Managing Director of Bergeson & Campbell, P.C., a Washington, D.C. law firm concentrating on conventional and nanoscale chemical, pesticide, and other speciality chemical product regulation and approval matters, domestic and international chemical classification, Food and Drug Administration law, and associated business issues. Ms. Bergeson is also President of The Acta Group, L.L.C. and The Acta Group EU, Ltd., B&C's consulting affiliates, with offices in Washington, D.C. and Manchester, U.K., respectively.
Ms. Bergeson counsels clients on health, safety, science policy, and related legal and regulatory aspects of traditional domestic chemical regualtory programs under FIFRA, TSCA, FFDCA, REACH, as well as issues pertinent to nanotechnology, biotechnology, and other emerging transformative technologies.
Ms. Bergeson serves on many editorial boards and in various leadership positions with the American Bar Association Section of Environment, Energy, and Resources. She also serves on the Board of Directors of Earth Day Network and served on the Board of Directors of the Environmental Law Institute for six years.
Recent book publications include: Nanotechnology: Environmental Law, Policy, and Business Considerations (
ABA Press 2009); Nanotechnology Deskbook
(ELI 2007); The Nanotechnology-Biotechnology Interface: Exploring Models for Oversight (
University of Minnesota, 2006). Other publications are available at http://www.lawbc.com